In the current research, we aimed to investigate whether NaNO3, via sialin, attenuates metabolic disorders, especially MASLD and T2DM, by modulating the inflammatory responses of MoMFs to balance immune homeostasis. The gene discussed is SLC17A5; the disease is Other metabolic disease.